Abbott Laboratories


Abbott Expanding Its Covid-19 Test To Asymptomatic People- Report

Abbott Laboratories (ABT) is now holding trials to try and expand its rapid Covid-19 test to people who show no symptoms of the virus, …

Abbott Scores $760M US Gov Deal For Rapid Covid-19 Saliva Test

The US government has awarded a $760 million contract to Abbott Laboratories (ABT) for the delivery of 150 million rapid BinaxNOW Point of …

Abbot Labs Rolls Out Coronavirus Antibody Test, Seeks to Produce 20 Million Tests by June

Abbott Laboratories (ABT) said it is rolling out a laboratory-based blood test which can detect antibodies designed to identify whether someone has had …

Will These 3 Coronavirus Stocks Lead the Market to Recovery?

Almost three months have passed since COVID-19 began its spread beyond China’s borders, and the market remains in free fall. Capping off another volatile week, stocks fell on Friday April 3 in response …

Analysts Weigh In on Three Healthcare Giants: Gilead Sciences, Inc. (GILD), Regeneron Pharmaceuticals Inc (REGN), Abbott Laboratories (ABT)

Analysts are weighing in on pharmaceutical giants Gilead Sciences, Inc. (NASDA:GILD), Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and Abbott Laboratories (NYSE:ABT) with mixed ratings.

Dividend Aristocrats & The Sharpe Ratio: Part 2 of 4

In Part 1, the efficacy of investing in the Dividend Aristocrats Index was discussed. In addition, the current list of Dividend Aristocrats sorted …

William Blair Assigns Outperform On Abbott Laboratories Shares

In a research report issued today, William Blair analyst Ben Andrew assigned an Outperform rating on Abbott Laboratories (NYSE:ABT). No price target was …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts